Skip to content

Pharmacist Mobile App Intervention in Pediatric Inpatient

Role of Clinical Pharmacy and Mobile Medical Applications in Detection and Minimization of Different Medication Errors in Hospitalized Patients From Adults and Children

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07254741
Enrollment
2000
Registered
2025-11-28
Start date
2024-03-12
Completion date
2024-09-12
Last updated
2025-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medication Safety in Pediatric Inpatients

Brief summary

The goal of this study is to learn whether a clinical pharmacist-led medication review, supported by medical mobile applications, can improve the safety and quality of care for hospitalized children. The study compares usual care with enhanced pharmacist involvement to understand whether this approach reduces medication-related problems and supports better clinical outcomes. The main questions this study aims to answer are: Does the pharmacist-led review help identify and prevent medication issues in pediatric inpatients? Can this intervention improve the overall quality of care during hospitalization? Does the use of mobile medical applications assist pharmacists in making safer medication decisions? Participants will: Receive either routine care or routine care plus daily medication review by a clinical pharmacist Have their medications assessed regularly to identify potential problems Be followed during their hospital stay to observe clinical outcomes

Interventions

Daily medication review conducted by a clinical pharmacist using mobile medical applications to identify potential medication-related problems and support safer prescribing decisions for hospitalized pediatric patients.

Sponsors

Beni-Suef University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
2 Years to 15 Years
Healthy volunteers
No

Inclusion criteria

Age between 2 and 15 years Admitted to the pediatric general inpatient ward Prescribed three or more medications during the hospital stay

Exclusion criteria

Length of hospital stay less than 48 hours Admission to the pediatric intensive care unit (PICU) Estimated life expectancy less than 24 hours

Design outcomes

Primary

MeasureTime frameDescription
Medication Errors IdentifiedFrom admission to hospital discharge (an average of 3-7 days)Number of medication errors detected during routine review of inpatient medication orders, including prescribing, dosing, frequency, and administration-related issues.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026